Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Perkinelmer (PKI)

Perkinelmer (PKI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 17,009,970
  • Shares Outstanding, K 111,974
  • Annual Sales, $ 2,884 M
  • Annual Income, $ 227,560 K
  • 60-Month Beta 1.19
  • Price/Sales 5.25
  • Price/Cash Flow 24.01
  • Price/Book 5.23
Trade PKI with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate 3.60
  • Number of Estimates 1
  • High Estimate 3.60
  • Low Estimate 3.60
  • Prior Year 1.35
  • Growth Rate Est. (year over year) +166.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
137.58 +10.42%
on 12/23/20
162.70 -6.63%
on 01/11/21
+12.05 (+8.62%)
since 12/22/20
3-Month
122.17 +24.34%
on 10/26/20
162.70 -6.63%
on 01/11/21
+26.71 (+21.33%)
since 10/22/20
52-Week
62.91 +141.47%
on 03/23/20
162.70 -6.63%
on 01/11/21
+51.09 (+50.67%)
since 01/22/20

Most Recent Stories

More News
Top Ranked Growth Stocks to Buy for January 21st

Top Ranked Growth Stocks to Buy for January 21st

PKI : 151.91 (+0.88%)
PHM : 48.89 (+2.80%)
HOLX : 75.70 (-0.29%)
GPK : 17.22 (-0.63%)
Zacks Industry Outlook Highlights: Mettler-Toledo International, Waters Corp, PerkinElmer and Bruker

Zacks Industry Outlook Highlights: Mettler-Toledo International, Waters Corp, PerkinElmer and Bruker

PKI : 151.91 (+0.88%)
WAT : 273.62 (+0.87%)
MTD : 1,234.72 (-0.81%)
BRKR : 60.84 (-0.03%)
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Oxford Immunotec Global PLC - OXFD

, /PRNewswire/ -- , founder and managing partner at , a national securities firm rated in the 2018 and 2019 ISS Securities Class Action Services Report and headquartered at the Empire State Building in...

PKI : 151.91 (+0.88%)
OXFD : 21.90 (-0.05%)
3 Reasons Why PerkinElmer (PKI) Is a Great Growth Stock

PerkinElmer (PKI) is well positioned to outperform the market, as it exhibits above-average growth in financials.

PKI : 151.91 (+0.88%)
Why PerkinElmer (PKI) Could Beat Earnings Estimates Again

PerkinElmer (PKI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

PKI : 151.91 (+0.88%)
Perion (PERI) Announces Encouraging Preliminary Q4 Results

Perion Network (PERI) posts upbeat fourth-quarter and 2020 preliminary financial results, on the back of strength in the advertising business and synergies from recent acquisitions.

MU : 82.28 (-3.21%)
PKI : 151.91 (+0.88%)
PERI : 13.90 (+4.83%)
SQ : 222.88 (+1.48%)
Preeclampsia Diagnostics Market Worth USD 2.52 Billion at 11.0% CAGR; Increasing Healthcare Expenditure to Boost Growth: Fortune Business Insights(TM)

The global preeclampsia diagnostics market size is anticipated to gain momentum from the increasing number of pregnancies owing to the complete lockdown amid the COVID-19 pandemic. The report further states...

BAYRY : 16.0200 (-0.99%)
PKI : 151.91 (+0.88%)
SIEGY : 80.3900 (+3.04%)
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Oxford Immunotec Global PLC Buyout

Rigrodsky Law, P.A. announces that it is investigating Oxford Immunotec Global PLC ("Oxford Immunotec") (NASDAQ GS: OXFD) regarding possible breaches of fiduciary duties and other violations of law related...

OXFD : 21.90 (-0.05%)
PKI : 151.91 (+0.88%)
Why You Should Retain Pacific Biosciences (PACB) Stock Now

Investor confidence is high on Pacific Biosciences (PACB) stock, courtesy of solid prospects.

HOLX : 75.70 (-0.29%)
PKI : 151.91 (+0.88%)
IDXX : 492.86 (-0.72%)
PACB : 37.42 (+3.06%)
Top Ranked Growth Stocks to Buy for January 20th

Top Ranked Growth Stocks to Buy for January 20th

SBH : 13.99 (-3.38%)
PKI : 151.91 (+0.88%)
FOCS : 51.64 (+1.85%)
AMX : 14.28 (+0.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

PerkinElmer, Inc. is a global leader committed to innovating for a healthier world. Their dedicated team of whole employees worldwide is passionate about providing customers with an unmatched experience as they help solve critical issues especially impacting the diagnostics, discovery and analytical...

See More

Key Turning Points

3rd Resistance Point 155.60
2nd Resistance Point 153.94
1st Resistance Point 152.92
Last Price 151.91
1st Support Level 150.24
2nd Support Level 148.58
3rd Support Level 147.56

See More

52-Week High 162.70
Last Price 151.91
Fibonacci 61.8% 124.58
Fibonacci 50% 112.81
Fibonacci 38.2% 101.03
52-Week Low 62.91

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar